scispace - formally typeset
D

Dheeraj Kalladka

Researcher at Imperial College London

Publications -  33
Citations -  2401

Dheeraj Kalladka is an academic researcher from Imperial College London. The author has contributed to research in topics: Stroke & Modified Rankin Scale. The author has an hindex of 14, co-authored 27 publications receiving 1585 citations. Previous affiliations of Dheeraj Kalladka include National Institute of Mental Health and Neurosciences & NHS Greater Glasgow and Clyde.

Papers
More filters
Journal ArticleDOI

Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study.

Aravinthan Varatharaj, +125 more
TL;DR: This is the first nationwide, cross-specialty surveillance study of acute neurological and psychiatric complications of COVID-19 and provides valuable and timely data that are urgently needed by clinicians, researchers, and funders.
Journal ArticleDOI

Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study.

TL;DR: Single intracerebral doses of CTX-DP up to 20 million cells induced no adverse events and were associated with improved neurological function and support further investigation of CTx-DP in stroke patients.
Journal ArticleDOI

Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study

TL;DR: Evaluation of tenecteplase in larger trials of patients with acute stroke seems warranted, and to use imaging biomarkers to inform the design of a definitive phase 3 clinical trial.
Journal ArticleDOI

Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial

Martin Dennis, +1271 more
- 19 Jan 2019 - 
TL;DR: Although the treatment reduced the occurrence of depression, it increased the frequency of bone fractures and these results do not support the routine use of fluoxetine either for the prevention of post-stroke depression or to promote recovery of function.
Journal ArticleDOI

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial

Rustam Al-Shahi Salman, +933 more
- 29 Jun 2019 - 
TL;DR: The results exclude all but a very modest increase in the risk of recurrent intracranial haemorrhage with antiplatelet therapy for patients on antithrombotic therapy for the prevention of occlusive vascular disease when they developed intracerebral haem orrhage.